- October 24, 2025 - Rose Pharma Inc., a clinical-stage biopharmaceutical company developing ROSE-010, a rapid-onset, short-duration GLP-1 therapy targeting both weight management and acute IBS pain, today announced that Chief Executive Officer Enda Kenny, PhD will present data from its recent clinical trial in weight management at #ObesityWeek2025 (sponsored by The Obesity Society) on Tuesday, November 4, 2025 at 7:30 p.m
Use the tools and knowledge that thousands of successful peptide users rely on
This approach theoretically prevents tolerance development and allows natural NNMT function to reset periodically
Children Full-B12 Injection should be used in children only if advised by the doctor
Hormone Imbalance Even subtle shifts in estrogen, testosterone, or cortisol can alter where your body stores fat